×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 6 Track C - Pharmacovigilance and Risk Management: Pharmacovigilance Systems/Models and eReporting
Session Chair(s)
Chanez Narimene Kebache, MBA
Director, Global Product Safety & Pharmacovigilance
Canopy Growth Corporation, Canada
The session will discuss different pharmacovigilance systems/models used by the industry for the continuous monitoring of therapeutic health products. The session will also include an update from Health Canada and a Q&A on eReporting.
Speaker(s)
Designing a Pharmacovigilance System - Options and Strategies
Miranda Dollen
Akebia Therapeutics, United States
Consultant
A Look at a Hybrid Pharmacovigilance System
Diana Basmadjian, RPh
Sanofi Canada Inc., Canada
Associate Director, Pharmacovigilance and Medical Information
Q&A: eReporting
Mary J. Raphael
Health Canada, Canada
Director, Marketed Health Products Safety and Effectiveness Information Bureau
with
Valerie Bergeron
Health Canada, Canada
Adverse Reaction Terminology Specialist, Marketed Health Products Directorate
Have an account?